Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://www.dovepress.com/targeting-dtl-induces-cell-cycle-arrest-and-senescence-and-suppresses--peer-reviewed-fulltext-article-OTT, but it redirected us to https://www.dovepress.com/targeting-dtl-induces-cell-cycle-arrest-and-senescence-and-suppresses--peer-reviewed-fulltext-article-OTT. The analysis below is for the second page.

Title[redir]:
Targeting DTL induces cell cycle arrest and senescence and suppresses | OTT
Description:
Targeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells Yu-Chia Chen,1,* I-shu Chen,1,* Guan-Jin Huang,2 Chi-hsiang Kang,1 Kuo-Chiang Wang,1 Min-Jen Tsao,3 Hung-Wei Pan4,5 1Department of Surgery, Division of General Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; 2Department of Pathology, National Chung Kung University Hospital, Tainan, Taiwan; 3Department of General Surgery, Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan; 4Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; 5Department of Applied Chemistry, National Pingtung University, Pingtung, Taiwan *These authors contributed equally to this work Background: Hepatocellular carcinoma (HCC) has an increasing incidence and high mortality. Surgical operation is not a comprehensive strategy for liver cancer. Moreover, tolerating systemic chemotherapy is difficult for patients with HCC because hepatic function is often impaired due to underlying cirrhosis. Therefore, a comprehensive strategy for cancer treatment should be developed. DTL (Cdc10-dependent transcript 2) is a critical regulator of cell cycle progression and genomic stability. In our previous study, the upregulation of DTL expression in aggressive HCC correlated positively with tumor grade and poor patient survival. We hypothesize that targeting DTL may provide a novel therapeutic strategy for liver cancer. DTL small interference RNAs were used to knock down DTL protein expression.Methods: A clonogenic assay, immunostaining, double thymidine block, imaging flow cytometry analysis, and a tumor spheroid formation assay were used to analyze the role of DTL in tumor cell growth, cell cycle progression, micronucleation, ploidy, and tumorigenicity.Results: Our results demonstrated that targeting DTL reduced cell cycle regulators and chromosome segregation genes, resulting in increased cell micronucleation. DTL depletion inhibited liver cancer cell growth, increased senescence, and reduced tumorigenesis. DTL depletion resulted in the disruption of the mitotic proteins cyclin B, CDK1, securin, seprase, Aurora A, and Aurora B as well as the upregulation of the cell cycle arrest gene p21. A rescue assay indicated that DTL should be targeted through TPX2 downregulation for cancer cell growth inhibition. Moreover, DTL silencing inhibited the growth of patient-derived primary cultured HCC cells.Conclusion: Our study results indicate that DTL is a potential novel target gene for treating liver cancer through liver cancer cell senescence induction. Furthermore, our results provide insights into molecular mechanisms for targeting DTL in liver cancer cells. The results also indicate several other starting points for future preclinical and clinical studies on liver cancer treatment. Keywords: DTL, cell cycle, senescence, TPX2, hepatocellular carcinoma

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌟 Strong Traffic: 100k - 200k visitors per month


Based on our best estimate, this website will receive around 100,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Doi.org might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

cells, cell, dtl, cancer, cycle, tpx, protein, liver, growth, expression, figure, sirna, hcc, results, skhep, dna, depletion, rtpcr, assay, senescence, carcinoma, phase, targeting, hepatocellular, progression, arrest, mrna, measured, gene, inhibition, study, human, cyclin, levels, tumor, analysis, increased, control, medium, quantitative, egfptpx, aurora, target, damage, transfected, kaohsiung, treatment, rna, data, senescent,

Topics {✒️}

sirna-treated sk-hep-1 cells vectors expressing egfp-h2b egfp-tpx2 fusion protein dtl-depleted sk-hep-1 cells real-time rt-pcr assays denticleless/ra-regulated nuclear matrix quantitative real-time rt-pcr citric acid/sodium phosphate control rnai-oligonucleotide-transfected cells e2f1-dependent gene transcription sk-hep-1 cell line β-gal staining solution si-dtl egfp-tpx-2 cells micronucleated sk-hep-1 cells egfp-h2b cell line anchorage-independent cell growth cell lines derived microscopic low-power field human beta-actin gene dove medical press targeting pr-set7/set8 sa-β-gal assay including fast-track processing sk-hep-1 cells transfected real-time rt-pcr plated sk-hep-1 cells cell cycle-regulated nuclear p53-transactivated proapoptotic genes cul4-based e3 ligases completely contact inhibited endpoint rt-pcr assays egfp-tpx2 protein levels endpoint rt-pcr assay expression vector pegfp-c1 multiple cell-cycle regulator stage-independent prognostic factor egfp-tpx2 cells compared treating advanced hcc induces cell apoptosis35 dr wen-huei chang quantitative rt-pcr assay target/β-actin ratio manuscript login prof hey-chi hsu hepatocyte growth factor favored authors cdna microarray analysis γ-tubulin protein expression sk-hep-1 cells contact-inhibited cells

Questions {❓}

  • Cellular senescence and tumor promotion: is aging the key?
  • Why publish with us?

External Links {🔗}(149)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Tag Manager
  • Google Universal Analytics

Libraries {📚}

  • jQuery

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Com/cm/ef49a3f1-d8c1-47d6-88fc-50e41130631f/airgap

6.5s.